DEBORAH YEARGIN: Open Payments
NPI 1760950182 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 11 payments from 8 companies in 2025. Trend: 2023 $94 · 2024 $101 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $34 |
| Janssen Biotech, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Organon LLC | 1 | $12 |
Products named: GLASSIA, SKYRIZI, TREMFYA, VYEPTI, ORENCIA, ULTOMIRIS, Ocrevus Zunovo, RENFLEXIS.
Industry payments across SC — which companies pay providers there.
